Checchi Capital Advisers, LLC Eli Lilly & CO Transaction History

Checchi Capital Advisers, LLC

$1.78 Billion
Q3 2024

A detailed history of Checchi Capital Advisers, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 10,743 shares of LLY stock, worth $8.55 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

10,743

Previous 10,977 2.13%

Holding current value

$8.55 Million

Previous $9.94 Million 4.24%

% of portfolio

0.53%

Previous 0.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $180,680 - $224,644	-234 Reduced 2.13%	10,743 $9.52 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $80,460 - $100,903	111 Added 1.02%	10,977 $9.94 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $27,241 - $36,444	46 Added 0.43%	10,866 $8.45 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $182,240 - $214,838	-347 Reduced 3.11%	10,820 $6.31 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $43,470 - $59,929	-100 Reduced 0.89%	11,167 $6 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $24,902 - $33,297	71 Added 0.63%	11,267 $5.28 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $52,496 - $61,654	169 Added 1.53%	11,196 $3.84 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $16,720 - $19,482	-52 Reduced 0.47%	11,027 $4.03 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $9,783 - $11,149	33 Added 0.3%	11,079 $3.58 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $114,836 - $134,835	-412 Reduced 3.6%	11,046 $3.64 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $392,401 - $487,655	1,672 Added 17.09%	11,458 $3.28 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $27,431 - $34,042	122 Added 1.26%	9,786 $2.7 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $37,007 - $45,542	167 Added 1.76%	9,664 $2.23 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $74,747 - $96,685	-414 Reduced 4.18%	9,497 $2.18 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $32,042 - $41,480	-195 Reduced 1.93%	9,911 $1.85 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $20,351 - $26,930	156 Added 1.57%	10,106 $1.71 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $42,988 - $49,724	-294 Reduced 2.87%	9,950 $1.47 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $59,888 - $72,075	-439 Reduced 4.11%	10,244 $1.68 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $27,738 - $34,332	233 Added 2.23%	10,683 $1.48 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $11,547 - $14,302	-108 Reduced 1.02%	10,450 $1.37 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $11,960 - $13,009	-112 Reduced 1.05%	10,558 $1.18 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $75,337 - $87,937	-680 Reduced 5.99%	10,670 $1.18 Million
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $20,592 - $24,238	-185 Reduced 1.6%	11,350 $1.47 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $78,895 - $88,386	-745 Reduced 6.07%	11,535 $1.34 Million
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $110,501 - $138,107	1,287 Added 11.71%	12,280 $1.32 Million
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $21,347 - $24,500	282 Added 2.63%	10,993 $938,000
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $14,545 - $17,169	196 Added 1.86%	10,711 $829,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $15,240 - $16,347	186 Added 1.8%	10,515 $888,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $796,056 - $883,542	10,329	10,329 $884,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Account

Checchi Capital Advisers, LLC Eli Lilly & CO Transaction History